[Form 4] ALBEMARLE CORP Insider Trading Activity

Rhea-AI Filing Summary

Sheorey Neal Ravi reported acquisition or exercise transactions in this Form 4 filing.

Albemarle Corporation’s Chief Financial Officer, Neal Ravi Sheorey, received an equity award of 4,490 shares in the form of restricted stock units at a grant price of $0 per share. These units vest 100% on 03/02/2029, subject to the terms of the applicable award agreement.

The filing also updates his reported holdings to a total of 20,931 shares after the transaction. This amount now includes 4,231 unvested restricted stock units that vest 100% on 02/22/2027, which are being reported as beneficially owned common stock to align reporting methodology among Albemarle insiders.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Sheorey Neal Ravi

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,490	$0.00	--

Holdings After Transaction: Common Stock — 20,931 shares (Direct)

Footnotes (1)

1. Restricted Stock Units vest 100% on 03/02/2029, subject to the terms of the award agreement. This filing reflects an update to the Reporting Person's holdings reported in Table 1, Column 5 of the last Form 4 filed on 11/10/2025. This amount has been revised to include 4,231 unvested RSUs (previously reported in Table 2 on a Form 4 filed on 2/26/2024) that vest 100% on 2/22/2027. Vesting of all RSUs are subject to the terms of the applicable award agreement. RSUs with time-based vesting conditions are being reported in Table 1, Column 5 as beneficially owned common stock for consistency in reporting methodology among reporting persons of the Issuer.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sheorey Neal Ravi

(Last) (First) (Middle)

ALBEMARLE CORPORATION

4250 CONGRESS ST., SUITE 900

(Street)

CHARLOTTE NC 28209

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALBEMARLE CORP [ ALB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		A		4,490(1)	A	$0	20,931(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted Stock Units vest 100% on 03/02/2029, subject to the terms of the award agreement.

2. This filing reflects an update to the Reporting Person's holdings reported in Table 1, Column 5 of the last Form 4 filed on 11/10/2025. This amount has been revised to include 4,231 unvested RSUs (previously reported in Table 2 on a Form 4 filed on 2/26/2024) that vest 100% on 2/22/2027. Vesting of all RSUs are subject to the terms of the applicable award agreement. RSUs with time-based vesting conditions are being reported in Table 1, Column 5 as beneficially owned common stock for consistency in reporting methodology among reporting persons of the Issuer.

Remarks:

	/s/ Corey E. Tanner, Attorney-in-fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.